This curriculum vitae summarizes Christopher J. Swearingen's education and professional experience. He received a Ph.D. in Biostatistics from the Medical University of South Carolina and has worked in both academic and private sector roles, currently serving as Senior Director of Biostatistics at Samumed. He has extensive experience conducting statistical analysis and providing methodology support for clinical research studies.

1. Christopher J. Swearingen Curriculum Vitae
University of Arkansas for Medical Sciences
Department of Pediatrics
Biostatistics, Slot 512-43 (501) 364-6639
1 Children’s Way (501) 364-1431
Little Rock, AR 72202 cswearingen@uams.edu
CONTACT
INFORMATION
Ph.D. – Biostatistics August 2009EDUCATION
Medical University of South Carolina, Charleston SC USA
M.S. – Biostatistics Decemeber 2006
Medical University of South Carolina, Charleston SC USA
B.A. – Psychology (Double Minor - Math & German) May 1995
Belmont University, Nashville TN USA
Senior Director, Biostatistics Aug 2014–PresentEMPLOYMENT
Samumed, San Diego, CA
Associate Professor Jul 2014–Jul 2014
Department of Pediatrics, College of Medicine (Primary Appointment)
Department of Genetics, College of Medicine (Secondary Appointment)
University of Arkansas for Medical Sciences
Associate Director, Pediatric Biostatistics Program Aug 2012–Jul 2014
Arkansas Children’s Hospital (ACH) Research Institute (ACHRI), Little Rock, AR
Assistant Professor (Secondary Appointment) Aug 2009–Jul 2014
Department of Biostatistics, Fay W. Boozman College of Public Health
University of Arkansas for Medical Sciences, Little Rock, AR
Assistant Professor Aug 2009–Jun 2014
Department of Pediatrics, College of Medicine (Primary Appointment)
Department of Genetics, College of Medicine (Secondary Appointment)
University of Arkansas for Medical Sciences
Research Assistant 2004-2006
Department of Biostatistics, Bioinformatics and Epidemiology
Medical University of South Carolina, Charleston, SC
Database Analyst 1995-2004
Health Outcomes Research, Department of Rheumatology / Immunology
Vanderbilt University Medical Center, Nashville, TN
Last Updated: July 16, 2014 1 of 26

2. American Statistical Association (ASA) 2005–
International Biometric Society, Eastern North American Region (ENAR) 2008–
Institute of Mathematical Statistics (IMS) 2008–
International Society for Bayesian Analysis (ISBA) 2008–
PROFESSIONAL
MEMBERSHIPS
ACH Victory Visions – “Crossing the Creek” Oct–2011
ASA Consulting Section Joint Statistical Meeting Travel Award Aug–2011
Best Contributed Paper Statistics and Data Analysis – SAS Global Forum Apr–2011
University of Arkansas for Medical Sciences Teaching Scholar 2009–2011
ACH Victory Visions – “Teamwork” Sep–2010
MD Anderson Bayesian Biostatistics Conference Travel Award Jan–2009
NIH/NINDS Biostatistics Training with Application to Neuroscience 2006–2009
Medical University of South Carolina Presidential Scholar Fellow 2007–2008
Medical University of South Carolina Presidential Scholar 2006–2007
HONORS AND
AWARDS
American Statistical Association (ASA)
Assistant Newsletter Editor, ASA Statistical Consulting Section Jul 2014–Present
Chair, Contributed Session at Joint Statistical Meeting (JSM) 2012 30 Jul-2012
“Contributed Oral Poster Presentations: Section on Statistical Consulting”
Organizer, Topic-Contributed Session at JSM 2011 2 Aug-2011
“Perspectives on Reproducible Research: Moving from Buzzword to Doctrine”
Newsletter Editor, ASA Statistical Consulting Section Jul 2011–Jun 2014
President, Central Arkansas ASA Chapter 2011
Vice-President, Central Arkansas ASA Chapter 2010
SERVICE
(PROFESSIONAL)
International Biometric Society, Eastern North American Region (ENAR)
Chair, Contributed Session at ENAR 2010 24 March–2010
“Methods for Combining Matched & Unmatched Case-Control Studies”
College of Medicine, University of Arkansas for Medical Sciences
Interviewer, Medical School Applicants 8 January–2011
Interviewer, Medical School Applicants 9 January–2010
Interviewer, Medical School Applicants 31 October–2009
SERVICE
(INSTITUTION)
Graduate School, University of Arkansas for Medical Sciences
Judge, Poster Session for Student Research Week 21 April–2010
Last Updated: July 16, 2014 2 of 26

3. Department of Pediatrics, University of Arkansas for Medical Sciences
Judge, Poster Session for Fellow’s Day 14 May–2013
Judge, Poster Session for Fellow’s Day 15 May–2012
Educational Scholarship Working Group (ESWOG) 2010–2011
Pediatric Biostatistics Program, University of Arkansas for Medical Sciences
Chair, Faculty Biostatistician Search Committee 2012–Present
Chair, Faculty Statistical Geneticist Search Committee 2012
Chair, Database Administration Manager Search Committee 2012
Member, Staff Biostatistician Search Committee 2012
Member, Business Officer Search Committee 2012
Member, Faculty Biostatistician Search Committee 2010
Member, Staff Biostatistician Search Committee 2010
Manager, Program Website 2010–Present
Interim Director (as needed) 2010–2012
Continuing Education
Central Arkansas Statistical Association Short Course 19 Apr–2013
“Logistic Regression”
UAMS Department of Pediatrics 12 Mar–2013
“Birkman Leadership Styles Workshop”
UAMS Department of Pediatrics 2011–2012
“Faculty Development Leadership Institute”
UAMS Department of Pediatrics 10 Nov–2011
“21st Annual Professional Development Day”
Vanderbilt Biostatistics Short Course 9-11 March–2011
“Regression Modeling Strategies”
UAMS Pediatric Biostatistics Workshop 19-20 Jan–2010
“Sample Size Analysis in Study Planning: Concepts and Issues”
Central Arkansas Statistical Association Short Course 13 Nov–2009
“Introduction to Meta-Analysis”
OTHER
PROFESSIONAL
ACTIVITIES
Last Updated: July 16, 2014 3 of 26

4. National Institiute of Health
National Institute of Digestive and Diabetes and Kidney Diseases (NIDDK)
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (O4) Jun–2014
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (O2) Jun–2014
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M5) Apr–2014
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M3) Apr–2014
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M4) Mar–2014
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M2) Mar–2014
• Ad-Hoc Panel Review Member ZDK1 GRB 9 (J2) Nov–2013
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (J3) Oct–2013
• Ad-Hoc Panel Review Member ZDK1 GRB-9 (J1) Oct–2013
• Panel Review Member Apr–2013
George M. O’Brien Urology Cooperative Research Centers Program
Journal Reviewer
Autoimmune Diseases 2013
Applied Mathematics and Computation 2013
Journal of Clinical Psychology in Medical Settings 2013
Postgraduate Medical Journal 2012
Journal of Pediatric Neurology 2012
Journal of Clinical Psychology in Medical Settings 2011
Journal of Clinical Rheumatology & Musculoskeletal Medicine 2010
Editorial Board
Advances in Medicine: Epidemiology section 2013
Last Updated: July 16, 2014 4 of 26

5. Mentoring
Kent Thompson May 2014– Jul 2014
Role: Mentor UAMS College of Public Health Preceptorship
Andrea Sutton Jul 2013– Dec 2013
Role: Co-Mentor UAMS College of Public Health Preceptorship
Paige Fisher Jun 2013– Sep 2013
Role: Co-Mentor Pediatric Biostatistics Summer Intern
Maggie Beetstra Jun 2012– Aug 2012
Role: Primary Mentor Pediatric Biostatistics Summer Intern
Maggie Beetstra Jun 2011– Jul 2011
Role: Primary Mentor ACHRI Summer Science Program
Mallik Rettiganti Jun 2010– Sep 2010
Role: Co-Mentor Pediatric Biostatistics Summer Intern
Elizabeth Calloway, ACH Clinical Nutrition Dietitian Spring 2010– Fall 2010
Role: Statistics Mentor MS Human Nutrition, University of Alabama, Dec 2010
Andrea Muffuletto Jun 2010– Jul 2010
Role: Statistics Mentor ACHRI Summer Science Program
Emily Spillyards, ACH Clinical Nutrition Dietitian Fall 2009–Spring 2010
Role: Statistics Mentor MS Human Nutrition, University of Alabama, May 2010
TEACHING
Classroom Teaching
Faculty Development Seminar Research Series Fall 2010–Spring 2011
• Expanded the Basic Biostatistics Box Lunch “3B” Seminar Series to Seven Monthly
Lectures:
Study Design and Conduct Sample Size
Analysis of Categorical Data Continuous Data Analysis
Linear Regression and ANOVA Advanced Regression
Survival Analysis
• CME credit offered through Pediatric Education office
• Supplemental Material and Video archived on UAMS Blackboard Intranet
Basic Biostatistics Box Lunch “3B” Seminar Series Spring 2010
• Developed and Implemented a Biostatistic lecture series for UAMS Pediatrics,
Arkansas Children’s Hospital and Research Institute Faculty, Staff and trainees
• Lectures included:
Sample Size Determination Grant Development
Understanding Diagnostic Test Results Choosing a Statistical Test
Last Updated: July 16, 2014 5 of 26

6. Continuing Education Presentations / Seminars
ACHRI Summer Science Seminar 4 June–2013
“Everything You Wanted To Know About Biostatistics. . . but were afraid to ask!”
UAMS Pediatric Biostatistics Training Seminar 5 April–2013
“Empirical Sample Size Determination using Simulation”
Pediatric Cardiology Inservice 19 Feb–2013
“REDCap Data Entry Tutorial”
Pediatric Cardiology Conference 7 Jan–2013
“Setup and Management of Study Data using REDCap:”
“A Demonstation”
Pediatric Cardiology Conference 9 July–2012
“Data Management 101:”
“The Good, the Bad, and the Excel Workbooks”
UAMS HeadStart Training 6 March–2012
“Inservice - Using REDCap for HeadStart Assessment Data Management”
Pediatric Cardiology Conference 20 June–2011
“Propensity Score Matching”
Health Research, Policy and Health Promotion Conference 17 May–2011
“Translational and Reproducible Research:
Considerations and Challenges Facing Today’s Statistician”
UAMS Pediatric Biostatistics Research In Progress Seminar 11 May–2011
“Reproducible Research”
Pediatric Cardiology Conference 2 May–2011
“Reproducible Research”
REDCap Consortium Webinar 11 Feb–2011
“Volunteer autism registry using REDCap Survey”
ACHRI Intramural Grant Seminar 19 Jan–2011
“Statistical Considerations for CUMG Submission”
UAMS Pediatric Fellows Education Conference 9 Dec–2010
“Knowing Which Test To Use”
REDCap Consortium Webinar 24 Sep–2010
“Lessons learned supporting educational and research projects using REDCap”
ACHRI Intramural Grant Seminar 29 June–2010
Last Updated: July 16, 2014 6 of 26

7. “Statistical Considerations for CUMG Submission”
UAMS Pediatric Biostatistics Training Seminar 15 June–2010
“Beta Regression Tutorial”
ACHRI Summer Science Seminar 7 June–2010
“Everything You Wanted To Know About Biostatistics. . . but were afraid to ask!”
Current
USDA/AFRI 2010-04682 Weber (PI) 4/1/2011 – 7/31/2015
Arkansas Grow Healthy Study
Role: Co-Investigator (0.6-1.2 calendar) $4,776,312
EXTRAMURAL
FUNDING (PEER-
REVIEWED)
NIH/NIDDK STTR 2R42DK079387-03 James (PI) 9/1/2012 – 7/31/2014
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity
Role: Co-Investigator (0.6 calendar) $389,762
Awarded
NIH PAR-11-242 Aitken (PI) 7/1/2014 – 6/30/2019
Generations In Families Talking Safe Sleep (GIFTSS)
Role: Co-Investigator (1.2 calendar) $2,403,411
Prior / Completed
NIH 1 UL1 RR029884 Lowery (PI) 1/1/2010 – 3/31/2014
UAMS Translational Research Institiute
Role: Pediatric Statistician (0.6-1.56 calendar) $19,900,000
USDA/AFRI 58-6251-8039 Weber (PI) 1/1/2012 – 9/30/2013
Delta Garden Study
Role: Faculty Statistician (0.6 calendar) $2,356,550
NIH 1 R21 ESO17311-01A2 Blossom (PI) 1/1/2011 – 08/31/2012
Neuroimmune Dysregulation with Trichloroethylene Exposure
Role: Co-Investigator (0.6 calendar) $404,120
CDC 5 R49 CE00975-3 Aitken (PI) 7/1/2010 – 2/18/2011
‘Strike-Out’ Child Passenger Injury Prevention
Role: Faculty Statistician (0.36 calendar) $249,995
NIH/NINDS 1 T32NS 4800701A1 Palesch (PI) 8/1/2006 – 7/31/2009
Biostatistics Training with Application to Neuroscience
Role: Pre-Doctoral Trainee $620,000
Last Updated: July 16, 2014 7 of 26

8. Current
Arkansas Department of Human Services Schaefer (PI) 9/1/2009 – 6/30/2014
ANGELS – Newborn Screening
Role: Faculty Statistician (1.2 calendar) $5,127,091
EXTRAMURAL
FUNDING
(CONTRACTUAL)
New York University Rheumatology Swearingen (PI) 3/1/2010 – 6/30/2014
Rheumatic Disease Surveillance and Health Outcomes
Role: PI of Contract (1.8 calendar) $224,872
Current
ACHRI / ABI # 037025 Swearingen (PI) Awarded – 9/5/2012
Biostatistics Core Support — High Performance Computing Cluster
Role: Principal Investigator $65,657
INTRAMURAL
FUNDING (PEER-
REVIEWED)
Prior / Completed
UAMS TRI Community Pilot Award Swearingen (Co-PI) 6/1/2012 – 3/30/2014
Development and Testing of a Mobile Electronic Data and Information Capture
Infrastructure: The MEDIC Project
Role: Co-PI (Judith L. Weber Co-PI) (0.6 calendar) $76,598
ACHRI/ABI Weber (PI) 09/15/2013 – 12/31/2013
ACHRI Childhood Obesity Prevention Research Program — Bridging Request
Role: Co-Investigator (0.6 calendar) $119,834
NIH CTN P20 GM103425 Mulkey (PI) 6/1/2012 – 5/31/2014
Biomarkers Predicting Early Brain Injury in Neonatal Congenital Heart Disease
Role: Co-Investigator (0.6 calendar) $150,000
ACHRI/ABI Mulkey (PI) 1/1/2011 – 5/31/2014
Pediatric Neurology Project Support
Role: Faculty Statistician (0.6 calendar)
UAMS TRI KL2 Career Development Redwine (PI) 8/1/2011 – 7/31/2013
Cardiovascular Risk Factor Surveillance Systems in Arkansas Youth
Role: Statistical Advisor
ACHI Statistical Oversight
Arkansas Center for Health Improvement Thompson (PI) 3/1/2011 – 6/30/2013
Role: Statistician (as needed)
ACHRI CUMG Mulkey (PI) 6/1/2011 – 5/31/2013
Brain MRI in Neonatal Hypoxic-Ischemic Encephalopathy
Role: Co-Investigator $24,201
Last Updated: July 16, 2014 8 of 26

9. ACHRI CUMG Reeves (PI) 6/1/2011 – 5/31/2013
ECHO Parameters Associated with Non-surgical Ductal Closure in Low Birth Weight Infants
Role: Co-Investigator $10,000
ACHRI Student/Staff Grant Irby (PI) 7/1/2011 – 6/30/2012
Anti-Factor Xa Prediction of ECMO Circuit Change
Role: Co-Investigator $2,000
ACHRI Student/Staff Grant Street (PI) 7/1/2011 – 6/30/2012
Enteral Feeding Algorithm Implementation in the CVICU
Role: Co-Investigator $2,000
ACHRI CUMG Pasala (PI) 12/1/2010 – 11/31/2012
Multimeric Patterns of Plasma von Willebrand Factor in Pediatric ECMO Patients
Role: Co-Investigator $20,000
ACHRI CUMG Perez Fournier (PI) 12/1/2010 – 11/31/2012
Prophylactic Surfactant Administration with Rapid Extubation
Role: Co-Investigator $20,000
Arkansas Biosciences Institute1
Com (PI) 1/1/2011 – 12/31/2012
Fat Free mass Index and Health Status in Pediatric Cystic Fibrosis
Role: Co-Investigator (0.6 calendar) $50,668
UAMS CCTR Rainmaker Pilot Grant Redwine (PI) 7/1/2010 – 6/30/2011
Cardiovascular Risk Factor Surveillance Systems in Arkansas Youth
Role: Co-Investigator (0.6 calendar) $50,000
PEER-REVIEWED
PUBLICATIONS
[51] Jeffs D, Dorman D, Brown S, Files A, Graves T, Kirk E, Meredith-Neve S, Sanders J, White B,
and Swearingen CJ. Effect of virtual reality on adolescent pain during burn wound care. J
Burn Care Res 2014; EPUB.
[50] Mireles-Cabodevila RL, E.and Chatburn, Thruman T, Zabala LM, Holt S, Swearingen CJ,
and Heulitt M. Mid-frequency ventilation (MFV): Proof of concept in an animal model. Respir
Care 2014; EPUB.
[49] Pasala S, Fiser RT, Stine KC, Swearingen CJ, and Prodhan P. von Willebrand Factor
Multimers in Pediatric Extracorporeal Membrane Oxygenation Support. ASAIO Journal
2014; 60(4):419–423. http://goo.gl/0G0sUl.
[48] Stein KC, Wahl EC, Liu L, Skinner RA, Schilden JV, Bunn RC, Montgomery CO, Suva LJ,
Aronson J, Becton DL, Nicholas RW, Swearingen CJ, and Lumpkin CK. Cisplatin inhibits
bone healing during distraction osteogenesis. J Orthop Res 2014; 32(3):464–470.
http://goo.gl/dJC8f1.
[47] 2
Mulkey SB and Swearingen CJ. Advancing neurologic care in the neonatal intensive care
unit with a neonatal neurologist. J Child Neurol 2014; 29(1):31–35. http://goo.gl/wAbew.
[46] Mulkey SB, Swearingen CJ, Melguizo MS, Schmitz M, Ou X, Ramakrishnaiah RH,
Glasier CM, Schaefer GB, and Bhutta AT. Multi-tiered analysis of brain injury in neonates
with congenital heart disease. Pediatr Cardiol 2014; 35:344–352. http://goo.gl/o4WkS.
1
Transferred to another Faculty Statistician after exceeding required effort level.
2
Selected as ACHRI President’s Choice Publication – http://goo.gl/yHsw8
Last Updated: July 16, 2014 9 of 26

10. [45] Byrnes JB, Swearingen CJ, Prodhan P, Fiser RT, and Dyamenahalli U. Antithrombin III
supplementation on Extracorporeal Membrane Oxygenation: Impact on heparin dose and
circuit life. ASAIO Journal 2014; 60(1):57–62.
[44] Wyrick DL, Bozeman AP, Dassinger MS, Jackson RJ, Maxson RT, Kelley KR, Mathews DL,
Li J, Swearingen CJ, and Smith SD. Persistent Gastrocutaneous Fistula: Factors affecting
need for closure. J Pediatr Surg 2013; 48(12):2506–2510.
[43] Mulkey SB, Swearingen CJ, Melguizo MS, Reeves RN, Rowell JA, Gibson N, Holland G,
Bhutta AT, and Kaiser JR. Academic proficiency in children after early congenital heart
disease surgery. Pediatr Cardiol 2013; 34:1772–1784. http://goo.gl/T97jra.
[42] Aitken ME, Miller BK, Anderson BL, Swearingen CJ, Monroe KW, Daniels D, O’Neill J,
Scherer LR, Hafner JW, and Mullins SH. Promoting use of booster seats in rural areas
through community sports programs. J Rural Health 2013; 29:s70–s78.
http://goo.gl/hBnZY.
[41] Dodgen AL, Dodgen AC, Swearingen CJ, Gossett JM, Dasgupta R, Butt W, Deshpande JK,
and Gupta P. Characteristics and hemodynamic effects of extubation failure in children
undergoing complete repair of tetralogy of fallot. Pediatr Cardiol 2013; 34(6):1455–1462.
http://goo.gl/rjsId.
[40] Blossom SJ, Melnyk SB, Rau JL, Swearingen CJ, Cooney CA, and Wessinger WD.
Metabolic changes and DNA hypomethylation in cerebellum are associated with behavioral
alterations in mice exposed to trichloroethylene postnatally. Toxicol Appl Pharmacol 2013;
269(3):269–269. http://goo.gl/1aifR.
[39] Kobayashi T, Kishimoto M, Swearingen CJ, Filopoulus MT, Ohara Y, Tokuda Y, Oshikawa H,
Yoshida K, Utsunomiya M, Kimura M, Matsui K, and Yazici Y. Differences in clinical
manifestations, treatment, and concordance rates with two major sets of criteria for Behçet’s
syndrome for patients in the US and Japan: data from a large, three-center cohort study.
Mod Rheumatol 2013; 23(3):547–553. http://goo.gl/sVDxr.
[38] McCarty HM, Tang X, Swearingen CJ, and Collins II RT. Comparison of the
electrocardiographic QTc duration in patients with supravalvar aortic stenosis with-vs-without
Williams syndrome. Am J Cardiol 2013; 111(10):1501–1504. http://goo.gl/dmtDT.
[37] Uppu SC, Dyamenahalli U, Sachdeva R, Imamura M, Morrow WR, Gossett J,
Swearingen CJ, and Vyas HV. Conal septal morphometrics can identify higher-risk
neonates with Tetralogy of Fallot. J Am Soc Echocardiogr 2013; 26(2):200–207.
http://goo.gl/opNCY.
[36] Sachdeva R, Frazier EA, Jaquiss RDB, Imamura M, Swearingen CJ, and Vyas HV.
Echocardiographic evaluation of ventricular assist devices in pediatric patients. J Am Soc
Echocardiogr 2013; 26(1):41–49. http://goo.gl/BAFYV.
[35] Brown CM, Lloyd EC, Swearingen CJ, and Boateng BA. Improving resident self-efficacy in
pediatric palliative care through clinical simulation. J Palliat Care 2012; 28(3):157–163.
http://goo.gl/3C1DN.
[34] Kennish L, Labitigan M, Budoff S, Filopoulus MT, McCracken WA, Swearingen CJ, and
Yazici Y. Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in
routine clinical care: A cohort study. BMJ Open 2012; 2:e001117. http://goo.gl/d5nio.
[33] Canon S, Basham K, Purifoy JA, and Swearingen C. Alternative approaches to expanding
pediatric urology services and productivity. J Urology 2012; 188(4 Suppl):1639–1642.
http://goo.gl/VhvvD.
[32] Garcia X, Kane J, Prodhan P, Bhutta A, Swearingen CJ, and Sachdeva R. A model for
providing improved care to chronic patients in cardiac intensive care unit. Congenit Heart
Dis 2012; 7(5):403–409. http://goo.gl/LEu8t.
Last Updated: July 16, 2014 10 of 26

11. [31] 3
Mulkey SB, Yap VL, Swearingen CJ, Riggins MS, Kaiser JK, and Schaefer GB. Quantitive
cranial magnetic resonance imaging in neonatal hypoxic-ischemic encephalopathy. Pediatr
Neurol 2012; 47(2):101–108. http://goo.gl/g1ojB.
[30] Knecht KR, Alexander ML, Swearingen CJ, and Frazier EA. NTproBNP as a marker of
rejection in pediatric heart transplant recipients. Pediatr Transplant 2012; 16(4):335–339.
http://goo.gl/pwGyO.
[29] 4
Bhutta AT, Schmitz ML, Swearingen C, James LP, Ward-Begnoche WL, Lindquist DM,
Glasier CM, Tuzcu V, Prodhan P, Dyamenahalli U, Imamura M, Jaquiss RDB, and
Anand KJS. Ketamine as a neuroprotective and anti-inflammatory agent in children
undergoing surgery on cardiopulmonary bypass: A pilot randomized, doubleblind
placebo-controlled trial. Pediatr Crit Care Med 2012; 13(3):328–337.
http://goo.gl/9ab01.
[28] Gibbons T, Frem J, Patil S, Smith C, Wakwe J, and Swearingen CJ. Non IgE-mediated cow
milk allergy is linked to early childhood clusters of commonly seen illnesses: A pilot study.
Clinical Pediatrics 2012; 51(4):337–344. http://goo.gl/NLfgD.
[27] Collins RT II, Aziz PF, Swearingen CJ, and Kaplan PB. Relation of ventricular ectopic
complexes to the QTc internal on ambulatory electrocardiograms in Williams Syndrome. Am
J Cardiol 2012; 109(11):1671–1676. http://goo.gl/eMP9u.
[26] Collins RT II, Gossett JM, and Swearingen CJ. Long-term survival of patients with resting
obstructive hypertrophic cardiomyopathy: More questions than answers. J Am Coll Cardiol
2012; 59:1730. http://goo.gl/TAk5k.
[25] Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, and Swearingen CJ5
on behalf of the NET-PD Investigators. Subject-Investigator reproducibility of the Unified
Parkinson’s Disease Rating Scale. Parkinson Relat Disord 2012; 18(3):230–233.
http://goo.gl/koMIZ.
[24] Brown C, Gephardt G, Lloyd C, Swearingen C, and Boateng B. Teaching palliative care skills
using simulated family encounters. MedEdPORTAL 2011; 8507. http://goo.gl/AYGBb.
[23] 6
Swearingen CJ, Tilley BC, Adams RJ, Rumboldt Z, Nicholas JS, Bandyopadhyay D, and
Woolson RF. Application of beta regression to analyze ischemic stroke volume in NINDS
rt-PA clinical trials. Neuroepidemiology 2011; 37(2):73–82. http://goo.gl/CZAyl.
[22] Byrnes J, McKamie W, Swearingen CJ, Gossett J, Prodhan P, Bhutta A, Chipman C,
Jaquiss R, Imamura M, and Fiser R. Hemolysis during cardiac extracorporeal membrane
oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric
population. ASAIO Journal 2011; 57(5):456–461. http://goo.gl/Hfcdq.
[21] 7
Thrailkill KM, Moreau CS, Swearingen CJ, Rettiganti MR, Edwards K, Morales AE,
Kemp SF, Frindik JP, and Fowlkes JL. Insulin pump therapy started at the time of diagnosis:
Effects on glycemic control and pancreatic beta cell function. Diabetes Technol Ther 2011;
13(10):1023–1030. http://goo.gl/Q0BDB.
[20] Howard RG, Pillinger MH, Gyftopoulos S, Theile R, Swearingen CJ, and Samuels J.
Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition:
Concordance between readers. Arthritis Care Res 2011; 63(10):1456–1462.
http://goo.gl/X5XY2.
[19] Garcia X, Jaquiss RDB, Srinivasan C, Imamura M, Swearingen C, Dassinger MS, and
Sachdeva R. Preemptive gastrostomy tube placement after Norwood Operation is
associated with improved survival to Stage 2 Palliation but more gastrointestinal
complications. J Pediatrics 2011; 159(4):602–607. http://goo.gl/9pHrQ.
3
Selected as ACHRI President’s Choice Publication — http://goo.gl/TrNYK
4
Selected as ACHRI President’s Choice Publication – http://goo.gl/1K8k3
5
Corresponding Author
6
Selected as ACHRI President’s Choice Publication – http://goo.gl/N5mE8
7
Selected as ACHRI President’s Choice Publication – http://goo.gl/xW6Qq
Last Updated: July 16, 2014 11 of 26

12. [18] Canon S, Purifoy J, Heulitt G, Hogan WR, Swearingen C, Williams MA, Alpert SA, and
D Young. Pediatric urology survey of electronic medical records: Usage and perspectives. J
Urology 2011; 186:1740–1745. http://goo.gl/h6ttz.
[17] Swearingen CJ, McCollum L, Daltroy LH, Pincus T, Dewalt DA, and Davis T. Screening for
low literacy in a rheumatology setting: More than 10% of patients cannot read
“Cartilage,”“Diagnosis,” “Rheumatologist,” or “Symptom”. J Clin Rheumatol 2010;
16(8):359–364. http://goo.gl/3EbND.
[16] Swigris JJ, Yorke J, Sprunger DB, Swearingen C, Pincus T, du Bois RM, Brown KK, and
Fischer A. Assessing dyspnea and its impact on patients with connective tissue
disease-related interstitial lung disease. Respiratory Med 2010; 104(9):1350–1355.
http://goo.gl/NRBmd.
[15] Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM, Siegel EL, and
Yazici Y. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ
(Multidimensional Health Assessment Questionnaire): Agreement with DAS28 (Disease
Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five
versus more than ninety seconds. Arthritis Care Res 2010; 62(2):181–189.
http://goo.gl/bL2uq.
[14] Swearingen AM, Loftus T, Ghaemmaghami V, Swearingen CJ, Salisbury H, Gerkin RD, and
Ferrara J. Extreme blood alcohol level is associated with increased reasouse use in trauma
patients. American Surgeon 2010; 76(1):20–24. http://goo.gl/QXbo.
[13] Ravina B, Swearingen C, Elm J, Kamp C, Kieburtz K, and Kim SYH. Long term
understanding of study information in research participants with Parkinson’s disease.
Parkinsonism Relat Disord 2010; 16(1):60–63. http://goo.gl/qFXQZ.
[12] Pincus T, Swearingen CJ, Luta G, and Sokka T. Efficacy of 1-4 mg per day of prednisone in
patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled withdrawal
clinical trial. Ann Rheum Dis 2009; 68:1715–1720. http://goo.gl/vDQXz.
[11] Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC,
and Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson
disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD)
experience. Arch Neurol 2009; 66(9):1099–1104. http://goo.gl/Lgf2T.
[10] Nicholas JS, Swearingen CJ, and Kilmer JB. Predictors of skin cancer in commercial airline
pilots. Occupational Med 2009; 59(6):434–436. http://goo.gl/gHQ7b.
[9] Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, and Tilley BC. Minority
enrollment in Parkinson’s disease clinical trials. Parkinsonism Relat Disord 2009;
15(4):258–262. http://goo.gl/OeyNO.
[8] Pincus T, Swearingen CJ, Bergman M, and Yazici Y. RAPID3 (Routine Assessment of
Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine
care: proposed severity categories compared to disease activity score and clinical disease
activity index categories. J Rheumatol 2008; 35(11):2136–2147. http://goo.gl/lAlYp.
[7] Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, and Yazici Y. Visual analog scales in
formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J
Rheumatol 2008; 35(8):1550–1558. http://goo.gl/4CiIL.
[6] Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, and
Tilley BC on behalf of NET-PD Investigators. Caffeine and progression of Parkinson disease.
Clin Neuropharmacol 2008; 31(4):189–196. http://goo.gl/weQ33.
[5] Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, and Patel SJ. The
effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 2008;
31(1):48–56. http://goo.gl/cckiX.
Last Updated: July 16, 2014 12 of 26

13. [4] Keenan RT, Swearingen CJ, and Yazici Y. Erythrocyte sedimentation rate and c-reactive
protein levels are poorly correlated with clinical measures of disease activity in rheumatoid
arthritis, systemic lupus erythematosus and osteoarthritis patients. Clin Exp Rheumatol
2008; 26(5):814–819. http://goo.gl/xXStn.
[3] Yazici Y, Sokka T, Kautiainen H, Swearingen C, Kulman I, and Pincus T. Long term safety of
methotrexate in routine clinical care: discontinuation is unusual and rarely the result of
laboratory abnormalities. Ann Rheum Dis 2005; 64(2):207–211. http://goo.gl/aqQNq.
[2] Pincus T, Swearingen C, Cummins P, and Callahan LF. Preference for nonsteroidal
antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in
patients with osteoarthritis. J Rheumatol 2000; 27(4):1020–1027. http://goo.gl/wL1O2.
[1] Pincus T, Swearingen C, and Wolfe F. Toward a multidimensional health assessment
questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological
status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 1999;
42(10):2220–2230. http://goo.gl/ZerfX.
AFFILIATED
PUBLICATIONS
[7] Jawaheer D, Olsen J, Lahiff M, Forsberg S, Lähteenmäki J, da Silveira IG, Rocha FA,
Magalhães Laurindo IM, Henrique da Mota LM, Drosos AA, Murphy E, Sheehy C, Quirke E,
Cutolo M, Rexhepi S, Dadoniene J, Verstappen SM, and Sokka T for QUEST-RA. Gender,
body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.
Clin Exp Rheumatol 2010; 28(4):454–461. http://goo.gl/LRHMc.
[6] Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R, Andersone D,
Badsha H, Baecklund E, Belmonte M, Craig-Müller J, da Mota LM, Dimic A, Fathi NA,
Ferraccioli G, Fukuda W, Géher P, Gogus F, Hajjaj-Hassouni N, Hamoud H, Haugeberg G,
Henrohn D, Hørslev-Petersen K, Ionescu R, Karateew D, Kuuse R, Laurindo IM, Lazovskis J,
Luukkainen R, Mofti A, Murphy E, Nakajima A, Oyoo O, Pandya SC, Pohl C, Predeteanu D,
Rexhepi M, Rexhepi S, Sharma B, Shono E, Sibilia J, Sierakowski S, Skopouli FN,
Stropuviene S, Toloza S, Valter I, Woolf A, H Yamanaka, and the QUEST-RA Study Group.
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32
countries in the QUEST-RA study. Arthritis Res Ther 2010; 12(2):R42.
http://goo.gl/mrmeF.
[5] Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Oeets T,
Baranauskaite A, Geher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J,
Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B,
Minnock P, Surland Knudsen L, Jacobs JWG, Calvo-Alen J, Lazovskis J, da Rocha Castelar
Pinheiro G, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T, and QUEST-RA Group.
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics,
and treatments in the QUEST-RA Study. Arthritis Res Ther 2009; 11:R7.
http://goo.gl/Beh0o.
[4] Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev-Petersen K, Luukkainen RK,
Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M,
Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimi´c A,
Nedovi´c J, Stankovi´c A, Bergman M, Toloza S, and Pincus T for the Questionnaires in
Standard Monitoring of Patients With Rheumatoid Arthritis Group. Remission and
rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis
Rheum 2008; 58(9):2642–2651. http://goo.gl/B6tni.
[3] Naranjo A, Sokka T, Descalzo MA, J Calvo-Alén, Hørslev-Petersen K, Luukkainen RK,
Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M,
Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S,
Pincus T, and QUEST-RA Group. Cardiovascular disease in patients with rheumatoid
arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008; 10(2):R30.
http://goo.gl/fZwDR.
Last Updated: July 16, 2014 13 of 26

14. [2] Sokka T, Häkkinen A, Kautiainen H, Maillefert JF, Toloza S, Mørk Hansen T, Calvo-Alen J,
Oding R, Liveborn M, Huisman M, Alten R, Pohl C, Cutolo M, Immonen K, Woolf A, Murphy E,
Sheehy C, Quirke E, Celik S, Yazici Y, Tlustochowicz W, Kapolka D, Skakic V, Rojkovich B,
Müller R, Stropuviene S, Andersone D, Drosos AA, Lazovskis J, Pincus T, and QUEST-RA
Group. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one
countries in a cross-sectional, international study.. Arthritis Rheum 2008; 59(1):42–50.
http://goo.gl/z0J6O.
[1] Sokka T, Kautiainen H, Toloza S, Mäkinen H, Verstappen SM, Lund Hetland M, Naranjo A,
Baecklund E, Herborn G, Rau R, Cazzato M, Gossec L, Skakic V, Gogus F, Sierakowski S,
Bresnihan B, Taylor P, McClinton C, Pincus T, and QUEST-RA Group. QUEST-RA:
quantitative clinical assessment of patients with rheumatoid arthritis seen in standard
rheumatology care in 15 countries. Ann Rheum Dis 2007; 66(11):1491–1496.
http://goo.gl/vtGxk.
OTHER
PUBLICATIONS [11] Swearingen CJ, Melguizo castro MS, and Bursac Z. Inflated Beta Regression: Zero, one,
and everything in between. SASR
Global Forum Proceedings 2012; 325:1–11.
http://goo.gl/NtrTp.
[10] Howard RG, Pillinger MH, Gyftopoulos S, Theile R, Swearingen CJ, and Samuels J.
Response to letter to the editor by Filippou MD, et al. on the article by Howard RG, Pillinger
MH, Gyftopoulos S et al. Reproducibility of Musculoskeletal Ultrasound for Determining
Monosodium Urate Deposition: Concordance Between Readers. Arthritis Care Res. 2011
Oct;63(10):1456162. doi: 10.1002/acr.20527. Arthritis Care Res 2012; 64(5):795–796.
http://goo.gl/Elwcf.
[9] Swearingen CJ, Melguizo castro MS, and Bursac Z. Modeling percentage outcomes: The
%Beta_Regression macro. SASR
Global Forum Proceedings 2011; Paper 335:1–12.
http://goo.gl/n2M0V.
[8] Melguizo castro MS, Stalnaker JR, and Swearingen CJ. Using Microsoft Access 2007
description of field names in tables as variable labels in SAS datasets. SASR
Global Forum
Proceedings 2011; Paper 236:1–5. http://goo.gl/omVrH.
[7] Gossett JM, Aitken ME, Miller BK, and Swearingen CJ. Contrast statements for binary
responses: Comparing and constrasting with PROC GLIMMIX. SASR
Global Forum
Proceedings 2011; Paper 216:1–10. http://goo.gl/zGzMt.
[6] Pincus T, Yazici Y, and Swearingen CJ. Quality control of a medical history: improving
accuracy with patient participation, supported by a four-page version of the multidimensional
health assessment questionnaire (MDHAQ). Rheum Dis Clin North Am 2009;
35(4):851–860. http://goo.gl/jWbSi.
[5] Pincus T, Mandelin AM, and Swearingen CJ. Flowsheets that include MDHAQ physical
function, pain, global, and RAPID3 scores, laboratory tests, and medications to monitor
patients with all rheumatic diseases: an electronic database for an electronic medical
record. Rheum Dis Clin North Am 2009; 35(4):829–842. http://goo.gl/GSgRJ.
[4] Pincus T, Askanase AD, and Swearingen CJ. A multi-dimensional health assessment
questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are
informative in patients with all rheumatic diseases. Rheum Dis Clin North Am 2009;
35(4):819–827. http://goo.gl/SMshB.
[3] Pincus T and Swearingen CJ. The HAQ compared with the MDHAQ: "keep it simple, stupid"
(KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual
clinical care. Rheum Dis Clin North Am 2009; 35(4):787–798. http://goo.gl/FSIdF.
[2] Swearingen CJ (Editor). Forty Years of Analytical Contributions to Biomedical Research,
1968 - 2008. (Department of Biostatistics, Bioinformatics and Epidemiology, College of
Medicine, Medical University of South Carolina, Charleston, SC, 2008).
http://goo.gl/VGAw0.
Last Updated: July 16, 2014 14 of 26

15. [1] Pincus T, Yazici Y, Bergman M, Swearingen C, and Harrington T. A proposed approach to
recognise "near-remission" quantitatively without formal joint counts or laboratory tests: a
patient self-report questionnaire routine assessment of patient index data (RAPID) score as
a guide to a "continuous quality improvement" strategy. Clin Exp Rheumatol 2006; 24(6
Suppl 43):S–60–5. http://goo.gl/akquh.
ORAL
PRESENTATIONS
[20] Jeffs D, Dorman D, Brown S, Files A, Graves T, Kirk E, Meredith-Neve S, Sanders J, White B,
and Swearingen C. Effect of virtual reality on adolescent pain during burn wound care. 45th
Annual Meeting of the American Burn Association 2013; p. #23. http://goo.gl/WBwFY.
[19] Bozeman AP, Dassinger MS, Jackson RJ, Maxson RT, Kelley KR, Mathews DL, Li J,
Swearingen CJ, and Smith SD. Persistent Gastrocutaneous Fistula: Factors affecting need
for closure. American Academy of Pediatrics National Conference & Exhibition 2012;
H2016:#18074. http://goo.gl/E3Gkz.
[18] Byrnes JW, Swearingen CJ, Parthak P, Fiser RT, and Dyamenahalli U. Effect of Antithrombin
supplementation in pediatric cardiac Extracorporeal Membrane Oxygenation. American
Academy of Pediatrics National Conference & Exhibition 2012; H2022:#17065.
http://goo.gl/j0KBr.
[17] Canon SJ, Recicar J, Swearingen CJ, Maxson RT, and Linam LE. The utility of initial and
follow-up ultrasound reevaluation for blunt renal trauma in children and adolescents.
American Academy of Pediatrics National Conference & Exhibition 2012; H1016:#18018.
http://goo.gl/H2W2v.
[16] Redwine K, Brown W, Binz T, and Swearingen C. Effect of environmental tobacco exposure
on blood pressure in children. Pediatric Academic Societies 2012; E-PAS2012:1450.6.
http://goo.gl/D5LyI.
[15] Swearingen CJ, Melguizo castro MS, and Bursac Z. Inflated beta regression: Zero, one, and
everything in between. SASR
Global Forum. 2012; Invited.
[14] Swearingen CJ. When data act weird: Challenges in modeling Non-Normal data. University
of Arkansas – Little Rock Biosciences Lecture. 2011; Invited.
[13] Canon S, Purifoy J, Basham K, and Swearingen C. Alternative approaches to expanding
pediatric urology services and productivity. American Academy of Pediatrics National
Conference 2011; #14226. http://goo.gl/xXE6u.
[12] Zakaria D, Frazier EA, Imamura M, Gossett J, Pye S, Knecht KR, Morrow WR, and
Swearingen C. Improved survival while waiting in pediatric patients listed for cardiac
transplantation. American Academy of Pediatrics National Conference 2011; #14930.
http://goo.gl/fZVJF.
[11] Garcia X, Sachdeva R, Bhutta A, Prodhan P, Swearingen C, and Kane J. A novel paradigm
for providing improved care to chronic patients in Cardiac Intensive Care Unit. American
Academy of Pediatrics National Conference 2011; #15251. http://goo.gl/Tg8f7.
[10] Melguizo castro MS8
, Stalnaker JR, and Swearingen CJ. VBA Microsoft Access 2007
macros to import formats and labels to SASR
. Western Users of SAS Software Conference
2011.
[9] Swearingen CJ. Discussion on “Perspectives on Reproducible Research: Moving from
Buzzword to Doctrine”. Joint Statistical Meetings. 2011.
[8] Ince DC, Swearingen C, and Yazici Y. Pain in children 9-15 years old using game
consoles/handhelds and mobile phones: Implications for policy makers. European League
Against Rheumatism 2011.
8
Received Junior Professional Award for the 2011 WUSS Conference
Last Updated: July 16, 2014 15 of 26

16. [7] Filopoulus M, Kimura M., Kishimoto M, Kobayashi T, Matsui K, Ohara Y, Oshikawa H,
Swearingen C, Tokuda Y, Utsunomiya M, Yazici Y, and Yoshida K. The difference of
concordance rates between two major criteria of Behcet’s syndrome in the United States
and Japan. European League Against Rheumatism 2011.
[6] Swearingen CJ, Melguizo castro MS, and Bursac Z. Modeling percentage outcomes: The
%Beta_Regression macro. SASR
Global Forum 2011; 335.
[5] Brown CM, Boateng BA, Lloyd C, and Swearingen CJ. Improving resident self-efficacy in
pediatric palliative care using clinical simulation. American Academy of Hospice and
Palliative Medicine & Hospice and Palliative Nurses Association 2011.
[4] Canon S, Purifoy J, Heulitt G, Hogan WR, Swearingen C, Williams MA, Alpert SA, and
D. Young. Pediatric urology survey of electronic medical records: Usage and perspectives.
American Academy of Pediatrics National Conference & Exhibition. 2010; #11828.
[3] Swearingen CJ and Nick TG. The bureaucracy of translational research: Regulatory
challenges facing the consulting statistician. Joint Statistical Meetings. Given as part of a
contributed session “Consulting for Translational Research: Emerging Issues and
Recommendations” 2010.
[2] Swearingen CJ, Bandyopadhyay D, Woolson RF, and Tilley BC. Performance of beta
regression in detecting independent group differences. Eastern North American Region
(ENAR) of the International Biometric Society. 2010.
[1] Swearingen CJ. Generalized linear models using the beta distribution. Central Arkansas
Statistical Association. Invited. 2009.
POSTER
PRESENTATIONS [25] Swearingen CJ and Kaiser JR. Propensity score matching to estimate effect of treating
transient newborn hypoglycemia. Pediatric Academic Societies 2013; E-PAS2013:3836.604.
http://goo.gl/bFjVE.
[24] Lohmann P, Swearingen CJ, and Kaiser JR. Partial exchange transfusions in newborns: Is it
just the hematocrit that is being lowered? Pediatric Academic Societies 2013;
E-PAS2013:3836.558. http://goo.gl/sZN6Q.
[23] Reeves DM, Kaiser JR, Gossett JM, Swearingen CJ, Malik S, and Sachdeva R. Antegrade
pulmonary artery diastolic velocity is associated with spontaneous closure of the ductus
arteriosus in extremely low birth weight infants. Pediatric Academic Societies 2013;
E-PAS2013:2923.418. http://goo.gl/dgy2h.
[22] Mulkey SB, Swearingen CJ, Melguizo MS, Reeves RN, Rowell JA, Kaiser JR, and Bhutta AT.
Predictors of academic achievement in children with a history of congenital heart disease
(CHD) surgery in infancy. Pediatric Academic Societies 2013; E-PAS2013:1532.433.
http://goo.gl/qX329.
[21] Redwine K, Binz T, Brown W, and Swearingen CJ. Blood pressure (BP) variability in children
with elevated BP. Pediatric Academic Societies 2013; E-PAS2013:1525.360.
http://goo.gl/ZfoHH.
[20] Binz T, Brown W, Swearingen CJ, and Redwine K. Determinants of hypertension (HTN) in
children. Pediatric Academic Societies 2013; E-PAS2013:1525.350.
http://goo.gl/Ydcwr.
[19] Boateng BA, Swearingen CJ, Bass LD, Farrar HC, and Blaszak RT. A self assessment rubric
to facilitate the measurement of pediatric milestones and development of ILPs: Lessons
learned. ACGME Annual Education Conference 2013; # 14.
[18] Irby KO, Swearingen CJ, Byrnes JW, Bryant J, Fiser RT, and Prodhan P. Therapeutic
Heparin Anti-Factor Xa concentrations are associated with freedom from circuit change in
children supported with ECMO. 42nd Critical Care Congress – Society of Critical Care
Medicine 2013; # 280.
Last Updated: July 16, 2014 16 of 26

17. [17] Garlick J, Linam W, Maples H, Furlong-Dillard J, Swearingen CJ, Brown A, and Green J. The
use of antimicrobials in respiratory disease in a PICU. 42nd Critical Care Congress –
Society of Critical Care Medicine 2013; # 723.
[16] Reeves DM, Kaiser JR, Gossett JM, Swearingen CJ, Malik S, and Sachdeva R. Antegrade
pulmonary artery diastolic velocity is associated with spontaneous closure of the Ductus
Arteriosus in extremely low birth weight infants. American Academy of Pediatrics National
Conference & Exhibition 2012; # 17838. http://goo.gl/npGzg.
[15] Kaiser JK, Mehl JK, Bornhorst JA, and Swearingen CJ. Pattern of initial newborn glucose
concentrations (before treatment or feeding) by gestational age. Pediatric Academic
Societies 2012; E-PAS2012:1536.643. http://goo.gl/bcXpT.
[14] Kaiser JK, Mehl JK, Bornhorst JA, and Swearingen CJ. Treatment of newborn hypoglycemia
improves student achievement test scores. Pediatric Academic Societies 2012;
E-PAS2012:2916.229. http://goo.gl/qYz9c.
[13] Linam WM, Gilliam CH, Joneycutt MD, Wisdom CM, Swearingen CJ, and Romero JR.
Parental perceptions about mandatory influenza immunization of pediatric healthcare
workers. Pediatric Academic Societies 2012; E-PAS2012:2915.207.
http://goo.gl/Femsa.
[12] Mulkey SB, Yap VL, Swearingen CJ, Kaiser JR, Riggins MS, and Schaefer GB. Follow-up
volumetric brain measurements associated with adverse neurodevelopmental outcomes in
newborn hypoxic ischemic encephalopathy (HIE). Pediatric Academic Societies 2012;
E-PAS2012:4505.54. http://goo.gl/2hT9r.
[11] Swearingen CJ and Kaiser JK. Using nomograms to visualize association of newborn
hypoglycemia and student achievement-test proficiency. Pediatric Academic Societies 2012;
E-PAS2012:2916.242. http://goo.gl/ES3qD.
[10] Jeffs D, Dorman D, Brown S, Files A, Goforth E, Graves T, Killebrew P, Kirk E,
Meredith-Neve S, Sanders J, White B, Braden E, Hill T, and Swearingen C. Comparison of
virtual reality and passive distraction on burn wound care pain in adolescents. 22nd Annual
Conference of the Society of Pediatric Nurses 2012.
[9] Jeffs D, Dorman D, Brown S, Files A, Goforth E, Graves T, Killebrew P, Kirk E,
Meredith-Neve S, Sanders J, White B, Braden E, Hill T, and Swearingen C. Comparison of
virtual reality and passive distraction on burn wound care pain in adolescents. 26th Annual
Conference, Southern Nursing Research Society 2012.
[8] Peeples SE, McCracken A, Swearingen C, and Miquel-Verges F. Neonatal and obstetric care
and counseling at the threshold of viability. American Academy of Pediatrics National
Conference 2011. http://goo.gl/B6XzZ.
[7] Melguizo castro MS, Stalnaker JR, and Swearingen CJ. Using Microsoft Access 2007
description of field names in tables as variable labels in SAS datasets. SASR
Global Forum
Proceedings 2011; #236.
[6] Gossett JM, Aitken ME, Miller BK, and Swearingen CJ. Contrast statements for binary
responses: Comparing and constrasting with PROC GLIMMIX. SASR
Global Forum
Proceedings 2011; #216.
[5] Clemmons JC, Worley KB, and Swearingen CJ. A comparison of clinical recommendations
and judicial decisions regarding adolescent sex offender registration. Association for
Behavioral and Cognitive Therapies Annual Convention. 2010.
[4] Brown CM, Boateng BA, Swearingen CJ, and Lloyd EC. Improving resident self-efficacy in
pediatric palliative care using clinical simulation. International Palliative Care Network Poster
Exhibition 2010; #37. http://goo.gl/osMbW.
[3] Byrnes J, McKamie W, Swearingen C, Bhutta A, Prodhan P, Imamura M, Jaquiss RDB, and
Fiser R. Hemolysis is increased in cardiac extracorporeal life support with roller-head
pumps as compared to centrifugal pumps. American Academy of Pediatrics National
Conference. 2010; #11559.
Last Updated: July 16, 2014 17 of 26

18. [2] Swearingen CJ and Bandyopadhyay D. Further development of semiparametric methods in
bayesian beta regression. Eastern North American Region (ENAR) of the International
Biometric Society. 2009.
[1] Swearingen CJ. Using concordance correlation and multiple imputation to combine two
different assessments of the same construct. Eastern North American Region (ENAR) of
the International Biometric Society. 2008.
PUBLISHED
ABSTRACTS
[97] Jeffs D, Dorman D, Brown S, Files A, Graves T, Kirk E, Meredith-Neve S, Sanders J, White B,
and Swearingen C. Effect of virtual reality on adolescent pain during burn wound care. J
Burn Care Res 2013; 34(Suppl 1):S75. http://goo.gl/ITDdC.
[96] Kerr GS, Yazici Y, Swearingen CJ, Espinoza LR, Treadwell EL, Sherrer YRS,
Mosley-Williams AD, Ince A, Nair RG, Ford TL, Huang J, and Nunziato CA. Patient versus
physician global assessments in ethnic patients with rheumatoid arthritis. Arthritis Rheum
2012; 64(10 Supp):2102.
[95] Frem J, Chu C, Swearingen CJ, Gibbons TE, and Fuchs GJ. The Modified WHO Protocol in
the management of severe acute malnutrition in developed countries: A pilot study. J Pediatr
Gastroenterol Nutr 2012; 55(Suppl 1):#273.
[94] Redwine KM, Brown W, Binz T, and Swearingen C. Effect of cardiovascular disease (CVD)
risk factors on blood pressure (BP) in children. Clin Transl Sci 2012; 5(2):147.
[93] Howard RNG, Samuels J, Gyftopoulos S, Krasnokutsky S, Leung J, Swearingen CJ, and
Pillinger MH. Presence of Gout is associated with increased Osteoarthritis prevalence and
severity. Arthritis Rheum 2011; 63(Supp):1083.
[92] Kerr GS, Sherrer YRS, Nair RG, Treadwell EL, Mosley-Williams AD, Mubashir AM,
Espinoza ER, Huang J, Swearingen CJ, and Yazici Y. Ethnic Minority Rheumatoid Arthritis
Consortium: A clinical registry of minority patients with Rheumatoid Arthritis. Arthritis
Rheum 2011; 63(Supp):2110.
[91] Ohara Y, Kishimoto M, Kobayashi T, Swearingen CJ, Filopoulous MT, Tokuda Y, Oshikawa H,
Yoshida K, Utsunomiya M, Kimura M, Okada M, Matsui K, and Yazici Y. Difference of
manifestations and treatment among Behcet’s Syndrome patients in the United States and
Japan. Arthritis Rheum 2011; 63(Supp):2396.
[90] Yazici Y, Filopoulos MT, and Swearingen CJ. Comparative effectiveness and time to
response among Abatacept, Adalimumab, Etanercept and Infliximab for the treatment of
Rheumatoid Arthritis in a real world routine care registry. Arthritis Rheum 2011;
63(Supp):2233.
[89] Yazici Y, Swearingen CJ, Nadkarni A, and Rosenblatt L. Comparative efficacy and tolerability
of biologic therapies in early Rheumatoid Arthritis utilizing a Bayesian approach. Arthritis
Rheum 2011; 63(Supp):1240.
[88] Yazici Y, Swearingen CJ, Sherrer YRS, Nair RG, Treadwell EL, Mosley-Williams AD,
Espinoza ER, Mubashir AM, Huang J, and Kerr GS. Disease activity levels and treatment
patterns amongst Ethnic Minority Rheumatoid Arthritis Consortium patients. Arthritis Rheum
2011; 63(Supp):2126.
[87] Yazici Y, Filopoulous MT, and Swearingen CJ. RAPID3 remission vs new ACR Rheumatoid
Arthritis Remission Criteria: RAPID3 has similar utility and may be used in everyday clinical
care. Arthritis Rheum 2011; 63(Supp):2461.
[86] Ince DC, Swearingen C, and Yazici Y. Pain in children 9-15 years old using game
consoles/handhelds and mobile phones: Implications for policy makers. Ann Rheum Dis
2011; 70(Suppl3):67.
Last Updated: July 16, 2014 18 of 26

19. [85] Kobayashi T, Kishimoto M, Swearingen C, Filopoulus M, Ohara Y, Tokuda Y, Oshikawa H,
Yoshida K, Utsunomiya M, Kimura M., Matsui K, and Yazici Y. The difference of concordance
rates between two major criteria of Behcet’s syndrome in the United States and Japan. Ann
Rheum Dis 2011; 70(Suppl3):160.
[84] Brown CM, Boateng BA, Lloyd EC, and Swearingen CJ. Improving resident self-efficacy in
pediatric palliative care using clinical simulation. J Pain Symptom Manage 2011;
41:231–232.
[83] Uppu SC, Dyamenahalli U, Sachdeva R, Jaquiss RD, Morrow WR, Gossett JM,
Swearingen CJ, and Vyas HV. Wider conal septal angle in neonates with Tetralogy of Fallot
is associated with rapid progression of right ventricular outflow tract obstruction. Circulation
2010; 122:A21484. http://goo.gl/GFn3l.
[82] Howard RG, Pillinger MH, Gyftopoulos S, Theile R, Swearingen C, and Samuels J.
Concordance between ultrasound readers determining the presence of monosodium urate
crystal deposition in the knee and toe joints. Arthritis Rheum 2010; 62(9 Supp):1616.
[81] Diaz MV, Shadakshari A, McCracken A, Swearingen C, Ricciardi D, and Yazici Y. In Systemic
Lupus Erythematosus (SLE) patients, patient reported outcomes and physician assessment
of disease activity are poorly correlated: Implications for outcome measures in SLE. Arthritis
Rheum 2010; 62(9 Supp):1863.
[80] Nowatzky J, Filopoulos MT, Swearingen C, and Yazici Y. Eye involvement in BehcetŠs
Syndrome patients in a North American cohort. Arthritis Rheum 2010; 62(9 Supp):1298.
[79] Yazici Y, Filopoulos MT, Schimmel E, McCracken A, and Swearingen C. Clinical
characteristics, treatment and ethnic/racial differences in the manifestations of 518
BehcetŠs Syndrome patients in the United States. Arthritis Rheum 2010; 62(9 Supp):1284.
[78] Yazici Y and Swearingen C. Etanercept, Adalimumab and Abatacept combination with
Methotrexate have lower odds ratios of discontinuations due to adverse events and serious
infections compared to Infliximab and Methotrexate combination: An analysis of RCT data.
Ann Rheum Dis 2010; 69(Supp 3):509.
[77] Labitigan M, Sharaf PH, Swearingen C, and Yazici Y. Rheumatoid arthritis patients who
participated in randomized clinical trials in 1980s versus 2000s: Clinical implications of
similarities and differences. Ann Rheum Dis 2010; 69(Suppl 3):508.
[76] Pincus T, Swearingen CJ, Bergman M, Colglazier CL, Kaell A, Kunath A, Siegel E, and
Yazici Y. Joint damage estimates by rheumatologists in patients with rheumatoid arthritis
(RA) are correlated similarly with swollen joint count, ESR and DAS28 as with patient
self-report scores for function, pain and global estimate. Ann Rheum Dis 2010; 69(Suppl
3):718.
[75] Masatlioglu S, Goktay F, Swearingen C, and Yazici Y. Comparison of RAPID3, DAS28,
BASDAI And PASI in Psoriatic Arthritis patients in routine care: RAPID3, composed of
patient measures only, is strongly correlated with DAS28, BASDAI and not with PASI. Ann
Rheum Dis 2010; 69(Suppl 3):700.
[74] Kushnir M, Ashurova A, Shriky R, Swearingen C, and Yazici Y. Infliximab, Abatacept And
Rituximab use in the treatment of rheumatoid arthritis in the real world: View from the
infusion unit. Ann Rheum Dis 2010; 69(Suppl 3):675.
[73] Pincus T and Swearingen CJ. Patient questionnaire scores for physical function and pain are
more likely than erythrocyte sedimentation rate (ESR) to document a quantitative
abnormality in new patients with rheumatoid arthritis (RA). Ann Rheum Dis 2010; 69(Suppl
3):674.
[72] Pincus T and Swearingen CJ. RAPID3 and component measures are as likely as a DAS28
and component measures to identify patients with rheumatoid arthritis (RA) who have
moderate/high disease activity versus low activity at presentation. Arthritis Rheum 2009;
60(10 Supp):1920.
Last Updated: July 16, 2014 19 of 26

20. [71] Pincus T and Swearingen CJ. Documenting adequate versus incomplete responses to
methotrexate (MTX) at initiation of biologic agents in routine clinical care, according to ESR,
RAPID3, and component patient-reported scores for physical function, pain and global
estimate. Arthritis Rheum 2009; 60(10 Supp):1627.
[70] Ince DC, Swearingen CJ, and Yazici Y. Wrist pain in 7-12 year olds playing with game
consoles/handhelds: Younger children have more pain, independent from time spent
playing. Arthritis Rheum 2009; 60(10 Supp):1234.
[69] Yazici Y, Schimmel E, and Swearingen CJ. Behcet’s Syndrome (BS) in the US: Clinical
characteristics, treatment and ethnic/racial differences in manifestations in 347 patients with
BS. Arthritis Rheum 2009; 60(10 Supp):649.
[68] Kurtulus D, Bahadir C, Swearingen CJ, and Yazici Y. Comparison of RAPID3, BASDAI and
BASFI in Ankylosing Spondylitis patients in routine care: RAPID3, composed of patient
measures only, is strongly correlated with BASDAI and BASFI. Arthritis Rheum 2009; 60(10
Supp):510.
[67] Pincus T and Swearingen CJ. DAS28 and RAPID3 based on patient questionnaire scores
are more likely than ESR to indicate a quantitative abnormality at initiation of methotrexate
therapy, to monitor improvement in status in 201 patients with rheumatoid arthritis. Arthritis
Rheum 2009; 60(10 Supp):432.
[66] Pincus T and Swearingen CJ. Decline of mean initial prednisone dose from 10.3 mg/day in
1980-1985 to 3.6 mg/day in 2000-2004 with similar efficacy over 12 subsequent months.
Arthritis Rheum 2009; 60(10 Supp):425.
[65] Pincus T and Swearingen CJ. Erythrocyte sedimentation rate (ESR) is the least likely of
Core Data Set measures to identify an "abnormal state" in new patients with RA to monitor
therapeutic responses, according to 3 definitions of “abnormal state”. Arthritis Rheum 2009;
60(10 Supp):318.
[64] Kobayashi T, Kishimoto M, Tokuda Y, Schimmel EK, Swearingen C, Yoshida K,
Utsunomiya M, Yamamoto M, and Yazici Y. Disease manifestations and treatment
differences among Behcet’s Syndrome patients in the United States and Japan. Ann Rheum
Dis 2009; 68(Supp III):609.
[63] Swearingen C and Yazici Y. A reappraisal of the ACR classification criteria for rheumatoid
arthritis: Do we need new criteria for early RA patients? Ann Rheum Dis 2009; 68(Supp
III):572.
[62] Yazici Y, Schimmel EK, and Swearingen C. Hispanic early RA patients report worse disease
measures at baseline than Caucasian or African American patients however all racial/ethnic
groups respond at similar levels to DMARD treatment at 2 years. Ann Rheum Dis 2009;
68(Supp III):735.
[61] Yazici Y, Kilfoy SM, Rognan TN, Ingber E, Swearingen C, Shriky R, and Ince A. Infusible
biologic use in an academic and a private setting: Different agents are preferred with same
low infusion reaction rates with very few discontinuations. Ann Rheum Dis 2009; 68(Supp
III):741.
[60] Khan NA, Spencer HJ, Swearingen C, Tammaru M, Géher P, da Mota LMH, da Silveira I,
Hansen T, Maillefert J, Alten R, Pohl C, Skopouli FN, Mavrommati M, Sharma B, Minnock P,
Murphy E, Cazzato M, Salaffi F, Shono E, Huisman M, Kapolka D, Sadkiewicz S, Dimic A,
Nedovic J, Naranjo A, Taylor P, McClinton C, and Sokka T. Determinants of discordance in
patients and physicians assessment of rheumatoid arthritis disease activity. Ann Rheum Dis
2009; 68(Supp III):563.
[59] Pincus T and Swearingen C. Prednisone in initial doses less than 5 mg/day is as efficacious
as larger doses in patients with rheumatoid arthritis (RA). Ann Rheum Dis 2009; 68(Supp
III):593.
Last Updated: July 16, 2014 20 of 26

21. [58] Pincus T and Swearingen C. Documenting incomplete response to methotrexate (MTX) in
standard clinical care at initiation of therapy with biologic agents, according to erythrocyte
sedimentation rate (ESR) and patient questionnaire scores for physical function and pain.
Ann Rheum Dis 2009; 68(Supp III):592.
[57] Pincus T and Swearingen CJ. Erythrocyte sedimentation rate (ESR) is less likely than
patient questionnaire scores for physical function and pain to indicate a quantitative
abnormality in 413 new patients with rheumatoid arthritis (RA), to assess status and monitor
clinical improvement. Ann Rheum Dis 2009; 68(Supp III):737.
[56] Pincus T and Swearingen CJ. Erythrocyte sedimentation rate (ESR) is less likely to indicate
a quantitative abnormality than patient questionnaire scores for physical function and pain at
initiation of methotrexate (MTX) therapy, to monitor improvement in status in 201 patients
with rheumatoid arthritis (RA). Ann Rheum Dis 2009; 68(Supp III):551.
[55] Pincus T, Yazici Y, Bergman M, and Swearingen CJ. Physician/assessor global estimate of
patient status: Analysis of intra-observer and inter-observer agreement. Ann Rheum Dis
2009; 68(Supp III):98.
[54] Pincus T, Swearingen C, Bergman M, Colglazier CL, Kaell A, Kunath A, Siegel E, and
Yazici Y. Joint damage estimates by rheumatologists in 250 patients with rheumatoid
arthritis (RA) are correlated at higher levels with swollen joint count, erythryocyte
sedimentation rate (ESR) and Disease Activity Score (DAS28), than with patient self-report
scores. Ann Rheum Dis 2009; 68(Supp III):767.
[53] Pincus T, Bergman M, Yazici Y, and Swearingen C. DAS28-ESR (Disease Activity Score
With Erythrocyte Sedimentation Rate) is correlated at similar levels with RAPID3 (Routine
Assessment Of Patient Index Data), an index of only patient self-report measures, as with
C-Reactive Protein (CRP) in patients with rheumatoid arthritis (RA). Ann Rheum Dis 2009;
68(Supp III):538.
[52] Fischer A, Swearingen C, du Bois RM, Swigris JJ, Yorke J, Ries AL, Kaplan RM, and
Pincus T. Multi-Dimensional Health Assessment Questionnaire self-report scores correlate
with self-report of dyspnea and pulmonary function tests in patients with rheumatic diseases
and pulmonary comorbidity. Ann Rheum Dis 2009; 68(Supp III):342.
[51] Forbess C, Swearingen C, and Yazici Y. Behcet’s Syndrome Activity Score (BSAS): A new
disease activity assessment tool, composed of patient-derived measures only, is strongly
correlated with the Behcet’s Disease Current Activity Form (BDCAF). Arthritis Rheum 2008;
58(11 Supp):1875.
[50] Yazici Y, Swearingen C, and Schimmel E. Hispanic early RA patients report worse disease
measures at baseline than Caucasian or African American patients however all racial/ethnic
groups respond at similar levels to DMARD treatment at 2 years. Arthritis Rheum 2008;
58(11 Supp):1385.
[49] Pincus T and Swearingen C. Documenting quality of rheumatology care with a quantitative
RAPID3 (Routine Assessment of Patient Index Data) score in every patient with any
rheumatic diagnosis at every visit using a 1-page Multidimensional Health Assessment
Questionnaire (MDHAQ). Arthritis Rheum 2008; 58(11 Supp):1583.
[48] Colglazier CL, Swearingen C, Kaell A, Kunath A, Siegel E, Bergman M, Yazici Y, and
Pincus T. Time to score indices to assess clinical status in RA: Disease Activity Score
(DAS28), Clinical Disease Activity Index (CDAI), Easy Rheumatoid Arthritis Measure
(ERAM) and Routine Assessment of Patient Index Data (RAPID3) in usual clinical care.
Arthritis Rheum 2008; 58(11 Supp):1582.
[47] Pincus T, Swearingen C, Bergman M, Colglazier CL, Kaell A, Kunath A, Siegel E, and
Yazici Y. Further evidence of significant associations of Routine Assessment of Patient Index
Data 3 (RAPID3) with Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index
(CDAI) in patients with rheumatoid arthritis (RA). Arthritis Rheum 2008; 58(11 Supp):1384.
Last Updated: July 16, 2014 21 of 26

22. [46] Pincus T and Swearingen C. First prednisone dose in 329 patients with rheumatoid arthritis
(RA) in one rheumatology practice: Reduction from 8.6 to 4.1 mg/day between 1982 and
2006. Ann Rheum Dis 2008; 67(Suppl II):612.
[45] Pincus T and Swearingen C. Efficacy of prednisone in doses of less than 5 mg/day in regular
clinical care of 123 patients with rheumatoid arthritis (RA) from 1986-2006. Ann Rheum Dis
2008; 67(Suppl II):612.
[44] Pincus T and Swearingen C. Documenting quality of rheumatology care with a quantitative
RAPID3 (Routine Assessment Of Patient Index Data) score in every patient at every visit
using a 1-page Multidimensional Health Assessment Questionnaire (MDHAQ). Ann Rheum
Dis 2008; 67(Suppl II):575.
[43] Forbess C, Swearingen C, and Yazici Y. Behcet’s Syndrome Activity Score (BSAS): A new
disease activity assessment tool, composed of patient-derived measures only, is strongly
correlated with the Behcet’s Disease Current Activity Form (BDCAF). Ann Rheum Dis 2008;
67(Suppl II):360.
[42] Pincus T, Yazici Y, Bergman MJ, Roth J, Sokka T, and Swearingen C. Simplified formats of
visual analog scales (VAS) for use in usual rheumatology clinical care: Agreement between
10 cm horizontal line and 21 numbered circles which require half the time to score. Ann
Rheum Dis 2008; 67(Supp II):310.
[41] Pincus T and Swearingen C. A randomized controlled withdrawal clinical trial documents the
efficacy of 1-4 mg per day of prednisone in patients with rheumatoid arthritis. Ann Rheum
Dis 2008; 67(Suppl II):203.
[40] Pincus T, Krishnaswami S, and Swearingen C. Prediction of mortality over 5-20 years in 210
patients with rheumatoid arthritis from 1985-2005 according to a Multidimensional Health
Assessment Questionnaire (MDHAQ), swollen joint counts with 28, 42 or 66 joints, age and
gender. Arthritis Rheum 2007; 56:S406.
[39] Pincus T and Swearingen C. Maintenance of improvement seen at 6 months over 5 years in
patients with rheumatoid arthritis treated in standard care according to a policy of "tight
control" using a Multidimensional Health Assessment Questionnaire (MDHAQ) and Routine
Assessment of Patient Index Data (RAPID3) scores at each visit. Arthritis Rheum 2007;
56:S111.
[38] Pincus T and Swearingen C. Efficacy of low dose prednisone (1-4 mg/day) in patients with
rheumatoid arthritis: A randomized controlled placebo controlled double-blind withdrawal
trial. Arthritis Rheum 2007; 56:S169.
[37] Pincus T, Yazici Y, Bergman M, and Swearingen C. Physician estimate of global status:
Analysis of intra-observer and inter-observer reliability. Ann Rheum Dis 2007; 66(Supp
II):632.
[36] Pincus T and Swearingen C. An index of only patient Multidimensional Health Assessment
Questionnaire (MDHAQ) data, Routine Assessment Of Patient Index Data (RAPID), at each
visit in standard care, to maintain “tight control” of rheumatoid arthritis over 5 years without
formal joint count. Ann Rheum Dis 2007; 66(Supp II):446.
[35] Pincus T, Yazici Y, Bergman M, and Swearingen C. Comparisons of a self-report
Rheumatoid Arthritis Disease Activity Index (RADAI) joint count to American College Of
Rheumatology (ACR) Core Data Set measures for rheumatoid arthritis (RA). Ann Rheum
Dis 2007; 66(Supp II):335.
[34] Pincus T and Swearingen C. Maintenance of improvement over 5 years in patients with
rheumatoid arthritis treated in standard care after 1996 according to a policy of tight control,
documented according to a Multidimensional Health Assessment Questionnaire (MDHAQ)
at each visit. Ann Rheum Dis 2007; 66(Supp II):335.
Last Updated: July 16, 2014 22 of 26

23. [33] Pincus T, Yazici Y, Bergman M, and Swearingen C. An index without formal joint counts,
Routine Assessment Of Patient Index Data (RAPID3), to help guide tight control of RA in
standard care: Most patients who meet DAS or CDAI remission or high activity criteria meet
identical preliminary RAPID criteria. Ann Rheum Dis 2007; 66(Supp II):271.
[32] Pincus T, Bergman M, Yazici Y, and Swearingen C. A composite index of physical function,
pain, patient global and joint count, RAPID4 (Routine Assessment Of Patient Index Data):
Virtually identical results with a patient self-report or physician/assessor joint count or no
joint count in RAPID3. Ann Rheum Dis 2007; 66(Supp II):270.
[31] Pincus T, Sokka T, Yazici Y, Bergman M, and Swearingen CJ. Comparisons of a self-report
Rheumatoid Arthritis Disease Activity Index (RADAI) joint count to physician-generated joint
counts and other American College of Rheumatology (ACR) Core Data Set measures for
rheumatoid arthritis (RA). Arthritis Rheum 2006; 54(9 Supp):2045.
[30] Pincus T, Bergman M, Yazici Y, and Swearingen CJ. How much does a visual analog scale
(VAS) for fatigue add to VAS measures of pain and global estimate? Arthritis Rheum 2006;
54(9 Supp):1765.
[29] Pincus T, Bergman M, Yazici Y, Roth J, and Swearingen CJ. Time to score various formats of
a Multi-Dimensional Health Assessment Questionnaire (MDHAQ): Which format would be
best for standard clinical care? Arthritis Rheum 2006; 54(9 Supp):1764.
[28] Pincus T, Yazici Y, Bergman M, Goodin V, Sokka T, and Swearingen CJ. Simplified formats of
visual analog scales for use in standard rheumatology clinical care: Agreement between a
10 cm horizontal line and 21 numbered circles. Arthritis Rheum 2006; 54(9 Supp):768.
[27] Swearingen C and Yazici Y. Low concordance between DAS28 and RAPID, a patient-only
scale, in a routine care rheumatoid arthritis cohort: What should be the “Gold Standard”?
Ann Rheum Dis 2006; 65(Suppl II):608.
[26] Pincus T and Swearingen CJ. Review of systems included on a Multi-Dimensional HAQ
(MDHAQ): Utility of a symptom checklist to recognize Fibromyalgia. Ann Rheum Dis 2006;
65(Supp II):559.
[25] Pincus T and Swearingen CJ. Variations in MDHAQ scores for physical function, pain,
fatigue, and global status are explained more by formal education level than by age or
duration of disease in all rheumatic diseases. Ann Rheum Dis 2006; 65(Supp II):598.
[24] Pincus T and Swearingen CJ. Utility of a multi-dimensional health assessment questionnaire
(MDHAQ) in all rheumatic diseases. Ann Rheum Dis 2006; 65(Supp II):598.
[23] Pincus T and Swearingen CJ. Quantitative clinical rheumatology: A 5 point scale for a
physician to record an estimate of prognosis in an individual patient in standard care. Ann
Rheum Dis 2006; 65(Suppl II):649.
[22] Pincus T and Swearingen CJ. A simple 3 point scale to assess diagnostic certainty in
standard rheumatology care: High certainty in about 50%, moderate certainty in about 40%,
and little or no certainty in about 10% of individual patients seen by one rheumatologist. Ann
Rheum Dis 2006; 65(Supp II):649.
[21] Pincus T, Bergman M, Yazici Y, and Swearingen CJ. How much does a visual analog scale
(VAS) for fatigue add to VAS measures of pain and global estimate? Arthritis Rheum 2006;
54(9 Supp):S704.
[20] Swearingen CJ, Rodgers JK, and Lackland D. Self-reported smoking and related health
behaviors in South Carolina: A geographic analysis of incidence rates of smoking-attributed
cancers. Ann Epi 2005; 15(8):661.
[19] Swearingen C and Yazici Y. DMARD therapy for rheumatoid arthritis (RA) in routine care:
Improved outcomes at 6 and 12 months, with more significant results in methotrexate
treated patients. Ann Rheum Dis 2005; 64(Suppl III):S218.
Last Updated: July 16, 2014 23 of 26

24. [18] Pincus T, Swearingen C, Sokka T, and Wolfe F. Patients who begin anti-TNF therapy in
standard clinical care at a U.S. academic rheumatology clinic include only 41% with disease
activity score (DAS) of > 5.1, while 63% have a self-report Apgar-like patient score on an
index of physical function, pain, patient global of > 7. Arthritis Rheum 2004; 50:S373.
[17] Yazici Y, Sokka T, Kautianinen H, Swearingen CJ, Kulman I, and Pincus T. Methotrexate
discontinuation is unusual in routine clinical care and rarely due to laboratory abnormalities.
Ann Rheum Dis 2004; 63(Supp I):S279.
[16] Pincus T, Swearingen CJ, and Sokka T. 10 activities of daily living (ADL) provide similar
information to 14 adl on a multi-dimensional health assessment questionnaire (MDHAQ).
Ann Rheum Dis 2004; 63(Suppl I):S520.
[15] Pincus T, Swearingen CJ, and Sokka T. Methotrexate results in similar levels of 50%
improvement after 6 months as cyclosporine, leflunomide, etanercept and infliximab in
routine clinical care, according to a patient self-report index and Erytrocyte Sedimentation
Rate. Ann Rheum Dis 2004; 63(Suppl I):S266.
[14] Yazici Y, Kulman I, Swearingen CJ, Sokka T, and Pincus T. Methotrexate hepatic toxicity in
rheumatoid arthritis patients is unusual. Arthritis Rheum 2003; 48:S322.
[13] Pincus T, Swearingen CJ, and Sokka T. Overcoming “floor effects” in the health assessment
questionnaire (HAQ) and modified health assessment questionnaire (MHAQ) with new
items. Arthritis Rheum 2003; 48:S402.
[12] Pincus T, Swearingen CJ, and Sokka T. A practical patient self-report multi-dimensional
health assessment questionnaire (MDHAQ) which provides scores for functional status,
pain, global status, fatigue, and psychological distress, on one side of one page, to be
“eyeballed” by a physician in 5 seconds and scored in <30 seconds. Arthritis Rheum 2003;
48:S458–S459.
[11] Pincus T, Swearingen CJ, and Sokka T. Methotrexate results in similar levels of 20% and
50% responses as cyclosporine, leflunomide, etanercept and infliximab in routine clinical
care, according to an index of functional status, pain and patient global scores, the 3 Core
Data Set measures for rheumatoid arthritis (RA) derived from patient self-report
questionnaires. Arthritis Rheum 2003; 48:S337.
[10] Pincus T and Swearingen CJ. A multi-dimensional health assessment questionnaire
(MDHAQ): Use in routine care of all rheumatic diseases with provision to meet health
services financial administration data requirements for complex visit. Arthritis Rheum 2001;
44(9):S186.
[9] Pincus T, Sokka T, Swearingen CJ, Swearingen T, Daltroy L, and Davis T. Analysis of a rapid
estimate of adult literacy in medicine (REALM) and education level in patients with
rheumatic diseases. Arthritis Rheum 2000; 43(9):S109.
[8] Pincus T, Wolfe F, Sokka T, Swearingen CJ, Callahan LF, Jordan J, and et al.
Gastrointestinal symptoms slightly less frequent in osteoarthritis patients taking
acetaminophen than Arthrotec (Diclofenac Na/misoprosotol) while efficacy of arthrotec was
significantly greater. Gastroenterology 2000; 118(4):A1294.
[7] Pincus T and Swearingen CJ. Do clinical trials in rheumatoid arthritis (RA) select for
“non-responder” patients? comparisons of earlier courses of patients with 6 or more versus
fewer than 6 swollen or tender joints. Arthritis Rheum 1999; 42:S350.
[6] Pincus T, Swearingen CJ, Hoekstra M, Callahan LF, Cummins P, and Lefkowith J. A survey
concerning experience of patients with osteoarthritis in use of acetaminophen and
nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1998; 41:S88.
[5] Pincus T, Swearingen CJ, Callahan LF, and Wolfe F. Documentation of effective care of
rheumatic diseases in routine clinical care using patient questionnaires. Arthritis Rheum
1998; 41:S226.
Last Updated: July 16, 2014 24 of 26

25. [4] Pincus T, Swearingen CJ, and Callahan LF. Use of a patient self-report questionnaire in a
complete history and differential diagnosis of new patients with rheumatic diseases. Arthritis
Rheum 1998; 41:S226.
[3] Pincus T, Swearingen CJ, and Callahan LF. Addition of 6 complex activities to a modified
health assessment questionnaire (MHAQ) to overcome “floor effects” in assessment of
functional capacity. Arthritis Rheum 1997; 40:S111.
[2] Pincus T, Swearingen CJ, and Callahan LF. A self-report cognitive symptoms inventory to
assess patients with rheumatic diseases: Results in eosinophilia-myalgia syndrome (EMS),
fibromyalgia, rheumatoid arthritis (RA), and other rheumatic diseases. Arthritis Rheum
1996; 39:S261.
[1] Livengood JM, Parris WCV, Moody L, Wood D, and Swearingen CJ. Integrative versus rote
memory in chronic pain patients - implications for a multidisciplinary pain treatment program.
Anesthesiology 1994; 81(3A):A1042.
SUBMITTED
[2] Canon S, Shera A, Phan M, Lapicz L, Scheidweiler T, Swearingen CJ, Batchelor L, and
Hurt R. Autonomic Dysreflexia during urodynamics in children and adolescents with Spinal
Cord Injury or severe neurologic disease. Submit to J Urol.
[1] Canon S, Recicar J, Head BT, Linam LL, Swearingen CJ, and Maxson T. The utility of inital
and follow-up ultrasound reevaluation for blunt renal trauma in children and adolescents.
Submit to J Pediatr Urol.
UNDER REVISION
[5] Boateng B, Swearingen CJ, and Blaszak RT. A self-assessment rubric to facilitate the
achievement of pediatric milestones: Development, validation and lessons learned.
[4] Irby OK, Prodhan P, Swearingen CJ, and Fiser RT. Unfractionated Heparin activity measured
by Anti-Factor Xa levels predicts the need for ECMO circuit changes: A retrospective pediatric
study.
[3] Linam WM, Storm EA, Bagwell HB, Shirm SW, Honeycutt M, Swearingen CJ, and Graham J.
Barriers and motivators of hand hygiene among healthcare workers in a pediatric emergency
department.
[2] Yazici Y, Swearingen CJ, Nadkarni A, Reed DM, Naci H, Fleurence R, and Rosenblatt L.
Comparative clinical efficacy and tolerability of biological treatments for early, methotrexate
naive Rheumatoid Arthritis patients.
[1] Zakaria D, Frazier E, Imamura M, Garcia X, Pye S, Knecht KR, Prodhan P, Gossett JR,
Swearingen CJ, and Morrow WR. Improved survival while waiting and risk factors for death
in pediatric patients listed for cardiac transplantation.
IN DEVELOPMENT
[6] Fisher PL, Wahl E, Lumpkin CK, and Swearingen CJ9
. Sensitivity analysis for two treatment
effects on tumor growth volume.
[5] Garcia X, Pye S, Swearingen CJ, Prodhan P, and Bhutta AT. Catheter associated blood
stream infections in intracardiac lines.
[4] Kaiser JK and Swearingen CJ. Initial plasma glucose concentrations and nadirs in ELGAN,
Preterm, Late Preterm, and Term newborns during the early postnatal period.
9
Corresponding Author
Last Updated: July 16, 2014 25 of 26

26. [3] Kilinc O, Gossett JM, Swearingen CJ, and Ratnasamy C. Do implantation guidelines predict
appropriate defibrillator therapy in children?
[2] Mulkey SB, Ou X, Ramakrishnaiah RH, Glasier CM, Swearingen CJ, Melguizo castro MS,
Yap V, Schmitz ML, and Bhutta AT. Analysis of White Matter Injury in newborns with
Congenital Heart Disease using Tract-Based Spatial Statistics.
[1] Reeves DM, Kaiser KR, Swearingen CJ, Malik S, and Sachdeva R. Echocardiographic
parameters associated with spontaneous closure of the Patent Ductus Arteriosus in
extremely low birth weight infants.
Last Updated: July 16, 2014 26 of 26